Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
NCT00227695
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
270
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
BIOLOGICAL:
rituximab
Sponsor
Swiss Cancer Institute